Tevogen (TVGN) Receivables - Other (2023 - 2026)
Tevogen's (TVGN) quarterly Receivables - Other came in at $158819.0 in Q2 2026, little changed on a YoY basis from $158819.0 in Q2 2025, and little changed quarter-over-quarter from $158819.0 in Q1 2026.
Analysis
Tevogen (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends
Tevogen (TVGN) has reported Receivables - Other for 4 consecutive years, with $158819.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Other changed 0.0% year-over-year to $158819.0; the trailing twelve-month figure through Jun 2026 stood at $158819.0 (changed 0.0% YoY), and the FY2025 full-year result was $158819.0, changed 0.0% from the prior year.
- Receivables - Other was little changed at $158819.0 in Q2 2026 per TVGN's latest filing, from $158819.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $344500.0 in Q4 2023 and bottomed at $158819.0 in Q1 2024.
- Historically, Receivables - Other has averaged $175699.1 across 4 years, with a median of $158819.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other slumped 53.9% in 2024, then changed 0.0% in 2025.
- Over 4 years, Receivables - Other stood at $344500.0 in 2023, then plunged by 53.9% to $158819.0 in 2024, then changed by 0.0% to $158819.0 in 2025, then changed by 0.0% to $158819.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $158819.0, $158819.0, and $158819.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 158,819.00 |
| Mar 31, 2026 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Dec 31, 2023 | 344,500.00 |